Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
5 Results for "
secretory vesicle
" in MedChemExpress (MCE) Product Catalog:
Products (5)
5 Results for "secretory vesicle" in MCE Product Catalog:
Target:
Research Areas:
α-Fluoromethylhistidine dihydrochloride is an orally active histidine decarboxylase inhibitor. α-Fluoromethylhistidine dihydrochloride depletes histamine in enterochromaffin-like (ECL) cells, reduces the number and volume density of secretory vesicles in ECL cells, and does not affect histamine storage in mast cells. α-Fluoromethylhistidine dihydrochloride abolishes Omeprazole (HY-B0113)-induced vacuolization of ECL cells and decreases gastrin-induced histamine efflux from ECL cells. α-Fluoromethylhistidine dihydrochloride does not alter the granular characteristics of ECL cells, omeprazole-induced hypertrophy of ECL cells, gastrin-induced pancreastatin-like immunoreactivity efflux, nor does it affect gastric acid secretion induced by histamine or vagal stimulation. α-Fluoromethylhistidine dihydrochloride inhibits basal and gastrin-stimulated gastric acid secretion, reduces acid output induced by gastrin+IBMX (HY-12318), but does not directly affect acid generation in isolated parietal cells .
Cat. No.: HY-W1015419
CAS No.: 73804-75-8
Synonyms: α-Fluoromethylhistidine
Target:
Research Areas:
α-FMH (α-Fluoromethylhistidine) is an orally active histidine decarboxylase inhibitor. α-FMH depletes histamine in enterochromaffin-like (ECL) cells, reduces the number and volume density of secretory vesicles in ECL cells, and does not affect histamine storage in mast cells. α-FMH abolishes Omeprazole (HY-B0113)-induced vacuolization of ECL cells and decreases gastrin-induced histamine efflux from ECL cells. α-FMH does not alter the granular characteristics of ECL cells, omeprazole-induced hypertrophy of ECL cells, gastrin-induced pancreastatin-like immunoreactivity efflux, nor does it affect gastric acid secretion induced by histamine or vagal stimulation. α-FMH inhibits basal and gastrin-stimulated gastric acid secretion, reduces acid output induced by gastrin+IBMX (HY-12318), but does not directly affect acid generation in isolated parietal cells .
Cat. No.: HY-D3161
CAS No.: 1234064-29-9
Target:
Research Areas:
Mini202 is a pH-responsive fluorescent false neurotransmitter with a pKa=6.4, and also serves as a substrate for vesicular monoamine transporters (VMAT1, VMAT2). Mini202 is widely applicable to studies related to cancer cells, transfected cells, adipose tissue, and other subjects .
Cat. No.: HY-P702054
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: VPS29; VPS29 Retromer Complex Component; Vacuolar Protein Sorting-Associated Protein 29; vesicle Protein Sorting 29; PEP11; DC15; DC7; PEP11 Homolog; HVPS29; Vacuolar Protein Sorting 29 Homolog (S. Cerevisiae); Epididymis secretory Sperm Binding Protein;
Species:
Human
Source:
E. coli
Cat. No.: HY-P702055
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: VPS29; VPS29 Retromer Complex Component; Vacuolar Protein Sorting-Associated Protein 29; vesicle Protein Sorting 29; PEP11; DC15; DC7; PEP11 Homolog; HVPS29; Vacuolar Protein Sorting 29 Homolog (S. Cerevisiae); Epididymis secretory Sperm Binding Protein;
Species:
Human
Source:
E. coli
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
